Article
Vitamin D may enhance chemo vs. androgen-independent PCa
New York-Adding high-dose vitamin D to docetaxel (Taxotere) in regimens for androgen-independent prostate cancer patients doubles the effectiveness of docetaxel as a single agent, according to results of a nonrandomized study from Oregon Health Sciences University, Portland.
Related Videos
Urologist discusses drug cost savings, price transparency
Neeraj Agarwal, MD, shares key takeaways from TALAPRO-2
Final Thoughts and Clinical Trials in NMIBC
Uptake of New Treatments in Urology Practice
Patient Communication and Treatment Adherence in NMIBC
Expert describes implications of neoadjuvant durvalumab approval in MIBC
Ian Metzler, MD, highlights recent advances in kidney stone technology
Ekene Enemchukwu, MD, on underutilization of vaginal estrogen for GSM
Sima Porten, MD, on gene-environment interactions in bladder cancer development
Resective Surgery and Minimally Invasive Procedures For BPH
Related Content
